Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04815876 · ClinicalTrials.gov registry record · NA
PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2
A NA study, sponsored by Weill Medical College of Cornell University.
- Completed
- Registry status
- NA
- Development phase
- 1,030
- Enrollment target
NCT04815876 is a NA study that has completed, run by Weill Medical College of Cornell University. The registered enrollment target is 1,030 participants.
The verdict
NCT04815876, a NA study, has completed, sponsored by Weill Medical College of Cornell University.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,030 participants
- Enrollment target
Study Summary
Approximately one million transrectal prostate biopsies are performed annually in the U.S., and the risk of post- biopsy infection is increasing due to greater antibiotic resistance of rectal flora. Preliminary data demonstrates that a transperineal MRI-targeted biopsy approach under local anesthesia compared to the standard practice transrectal MRI-targeted prostate biopsy has a much lower risk of infection, comparable pain/discomfort and may improve detection of prostate cancer. This randomized controlled trial will be the first prospective study to evaluate in-office transperineal MRI targeted prostate biopsy. The investigators hypothesize that a transperineal MRI-targeted biopsy approach under local anesthesia compared to the standard practice transrectal MRI-targeted prostate biopsy has a much lower risk of infection, comparable pain/discomfort and may improve detection of prostate cancer.
Interventions
- PROCEDURE Transperineal MRI-guided prostate biopsy
- PROCEDURE Transrectal MRI-guided prostate biopsy
- DRUG Antibiotic (prophylaxis)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,030 participants |
| Start Date | 2021-06-24 |
| Est. Completion | 2025-10-11 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04815876
The ClinicalTrials.gov registry entry for NCT04815876 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,030 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Weill Medical College of Cornell University, which has 701 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Transperineal MRI-guided prostate biopsy is the first listed.
NCT04815876 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04815876 about?
NCT04815876 is a clinical study titled "PReclude Infection EVEnts With No Prophylaxis Transperineal Biopsy 2". Approximately one million transrectal prostate biopsies are performed annually in the U.S., and the risk of post- biopsy infection is increasing due to greater antibiotic resistance of rectal flora. Preliminary data demonstrates that a transperineal MRI-targeted biopsy approach under local anesthesi...
What is the current status of trial NCT04815876?
This trial is currently completed. It is a NA study. The enrollment target is 1,030 participants. The study started on 2021-06-24. Estimated completion is 2025-10-11.
What interventions are being tested in trial NCT04815876?
The interventions under investigation include: Transperineal MRI-guided prostate biopsy (PROCEDURE), Transrectal MRI-guided prostate biopsy (PROCEDURE), Antibiotic (prophylaxis) (DRUG).
Who is sponsoring clinical trial NCT04815876?
This trial is sponsored by Weill Medical College of Cornell University, which has 701 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.